Oakland Southfield Physicians

OSP News

Medicaid Covers New Weight Loss Medications

Posted: 04/08/2022

The Michigan Medicaid Health Plan Common Drug Formulary has been updated to include additional medications for weight loss. Changes related to weight loss medications effective February 1, 2022 include:

Drug Class

Drug Name

New Status

Anti-Obesity – Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists

Saxenda

Wegovy

Covered on formulary with Prior Authorization and Age Edit - Preferred

Anorexiant Combinations

Qsymia

Covered on formulary with Prior Authorization and Age Edit - Preferred

Anti-Obesity – Fat Absorption Decreasing Agents

Xenical

Covered on formulary with Prior Authorization and Age Edit - Preferred

Each Medicaid Health Plan (MHP) may be less restrictive in their coverage status of these medications. As part of the Common Formulary, minimum requirements are established for drug utilization management policies such as quantity limits, age and gender edits, prior authorization criteria and step therapies. MHPs may be less restrictive, for products whose drug class(es) are not present on the Single Preferred Drug List, but not more restrictive, than the coverage parameters of the Common Formulary.

Click here for the Medicaid Health Plan Common Formulary.

We value your privacy. We use cookies and other technologies to keep the web site reliable and secure, tailor your experience, and measure web site performance, as described in our Privacy Policy.

x

OSP Technical Support